Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,289 | 9,565 | 19,866 | 35,704 | 57,165 |
| TOTAL | $24,250 | $10,453 | $20,530 | $36,572 | $57,940 |
| Non-Current Assets | |||||
| PPE Net | 757 | 1,090 | 419 | 345 | 356 |
| Other Non-Current Assets | 467 | 532 | 642 | 286 | 364 |
| TOTAL | $1,224 | $1,622 | $1,060 | $630 | $720 |
| Total Assets | $25,474 | $12,076 | $21,590 | $37,202 | $58,659 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,585 | 9,179 | 5,478 | 3,855 | 3,443 |
| Other current liabilities | 1,718 | 16,121 | 5,972 | N/A | N/A |
| TOTAL | $9,388 | $25,359 | $11,502 | $3,990 | $3,563 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,792 | 1,876 | 1,935 | 166 | 302 |
| TOTAL | $1,792 | $1,876 | $1,935 | $166 | $302 |
| Total Liabilities | $11,179 | $27,235 | $13,437 | $4,157 | $3,865 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,534 | 1,074 | 324 | 203 | 168 |
| Common Shares | 1 | 0 | 0 | 0 | 1 |
| Retained earnings | -247,343 | -202,761 | -159,990 | -150,898 | -126,775 |
| Other shareholders' equity | 0 | 0 | 0 | 1,382 | 18,888 |
| TOTAL | $14,295 | $-15,159 | $8,153 | $33,045 | $54,795 |
| Total Liabilities And Equity | $25,474 | $12,076 | $21,590 | $37,202 | $58,659 |